Objective
This STREP, coordinated and lead by an SME, will focus on the development of new malaria vaccine candidates with the aim of taking at least one product to the stage of pilot scale up at GLP standard. Products showing most promise, once expressed in the Tetrahymena system, will proceed to antigen testing in vitro and in vivo, to assess their structure and antigenic integrity. We expect to be able to produce at least one product for lead optimisation, safety and toxicology testing according to GLP standards. Combining the expertise of the two university malaria research laboratories with the novel Ciliate-based expression system in development by the SME, will generate several recombinant Tetrahymena thermophila expressing malaria antigens based primarily upon MSP-1 and the var2CSA genes of Plasmodium falciparum. To utilise the capabilities of the participants to the greatest efficiency, (both from the SME and two leading European universities), this STREP will consist of five workpackages: WP1: Project Management WP2: Development of transgenic Tetrahymena expressing MSP-1 Block 2 antigens WP3: Development of transgenic Tetrahymena expressing var2 CSA antigens WP4: GLP pilot scale production and purification of antigens expressed in Tetrahymena WP5: Testing and validation of candidate vaccines This STREP application, coordinated by Cilian AG, will provide an expression platform that is easily able to combine antigens, to develop combinatorial vaccines that may be more promising than the vaccines currently in development. Ciliate-based expression of Plasmodium falciparum proteins in secreted, membrane bound or cytosolic forms will complement the work being done as part of other larger European malaria vaccine development projects.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences infectious diseases malaria
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences basic medicine toxicology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2005-LIFESCIHEALTH-7
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
MUENSTER
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.